Emend Interactions
There are 448 drugs known to interact with Emend (aprepitant), along with 1 disease interaction. Of the total drug interactions, 75 are major, 348 are moderate, and 25 are minor.
- View all 448 medications that may interact with Emend
- View Emend disease interactions (1)
Most frequently checked interactions
View interaction reports for Emend (aprepitant) and the medicines listed below.
- albuterol
- Aloxi (palonosetron)
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Compazine (prochlorperazine)
- cyclophosphamide
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- dexamethasone
- famotidine
- gabapentin
- levothyroxine
- lorazepam
- magnesium oxide
- MiraLAX (polyethylene glycol 3350)
- Neulasta (pegfilgrastim)
- Nexium (esomeprazole)
- Norco (acetaminophen / hydrocodone)
- omeprazole
- ondansetron
- oxycodone
- pantoprazole
- Phenergan (promethazine)
- prednisone
- prochlorperazine
- ranitidine
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Emend disease interactions
There is 1 disease interaction with Emend (aprepitant) which include:
More about Emend (aprepitant)
- Emend consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: NK1 receptor antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.